Steris reports Q2 adjusted EPS $2.03, consensus $2.01

Reports Q2 revenue $1.34B, consensus $1.3B. “We are pleased to see the momentum in our Healthcare segment continue in the second quarter,” said Dan Carestio, CEO. “In addition, the integration of the surgical instrumentation business purchased from BD during the quarter is progressing as planned. Our Healthcare segment is anticipated to outperform our original expectations for the fiscal year, offsetting macro challenges impacting demand in our other segments.”